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Introduction Figure 1: 
As in other countries throughout the world, smoking in Malta is Smoking prevalence in Malta 
a widespread problem associated with significant morbidity and 
mortality. Being a primary advocate for community health care, the 
family doctor is ideally placed to provide counselling on smoking 
prevention and cessation. This paper endeavors to assist family 
doctors in managing tobacco abuse in family practice. 
Definition of smoking and related facts 
The definition of smoking fits the World Health Organisation (WHO) 
critelia for addiction adapted by Steele l as follows the compulsion to 
take a drug (nicotine) on a continuous basis (200 shots a day) in order 
to experience its effects (small doses stimulate, large doses sedate), 
or to avoid the discomfort of its absence (anxiety, initability, tremor, 
loss of concentration, memory impairment, insomnia, constipation, 
weight gain, craving). 
Smoking starts off as a psychosocial habit. Twenty cigarettes a 
day translate into 200 hand-to-mouth movements and puffs a day, 
6,000 a month, 72,000 a year, or more than 2,000,000 for a 45-
year-old smoker who starred at 15 years of age!! This habit rapidly 
develops into pharmacological dependence on tobacco, due to its 
constituent nicotine. The latter substance reaches the brain vvithin 7 
seconds of inhaling, twice as fast as if it were injected intravenouslyl. 
In fact, cJ'a\~ng occurs \¥ithin minutes of finishing a cigarette, due to 
the short half-life nicotine has in the body. 
In 1998, the WHO) issued the follO\¥ing statements of fact 
about tobacco smoking: 
• Tobacco products have no safe level of consumption. 
• They are the only legal consumer products that cause ill health 
and premature death when used exactly as the manufacturer 
intends. 
• Unless concerted action is taken quickly, 250 million of today's 
chi ldren will die prematurely from an avoidable cause - tobacco 
use. 
Local epidemiology 
Prevalence 
Smoking prevalence among the Maltese public (Figure 1) shows that, 
among children, girls are smoking more than boys (31 % versus 25%)', 
while, over the age of 16 years, more males than females smoke (33% 
versus 21 %)5. On the other hand, less doctors are smoking now 
than before. While in 198925% of doctors and dentists smoked", 
in 2000 only 15% of family doctors did so' . 
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Over the past ten years or so, smoking in Malta is calculated to have 
been responsible for approximately 350 deaths a year, i.e. about one 
death every dayS. 
Smoking habits 
In a study of the smoking habits of applicants for smoking cessation 
clinics in Malta9 , 57% believed that they would not be smoking 
one year later and 72% thought they would be much healthier after 
quitting. However, quitting smoking is easier said than done, as 
84% had tried to quit before and failed. As 94% of applicants to 
stop-smoking clinics believed in quittingl¥ith help, this indicates that 
Maltese smokers do feel the need for assistance to stop. 
Risks of smoking & benefits of quitting 
From their 50-year study of Blitish male doctors, Doll et al lll calculated 
that, on average, cigarette smokers die about 10 years earlier than 
non-smokers . Smokers smoke for the addictive effects of nicotine, 
but suffer the morbid and mortal effects of carbon monoxide and 
smoke condensate (known as 'tar') While nicotine acts on the brain 
and circulation, carbon monoxide prevents blood from carr)~ng the 
maximum amount of oxygen to the body's tissues, toge ther resulting 
in coronary artery disease, stroke and pelipheral vascular disease. Tar 
contains 4,000 different chemicals that lead to chronic bronchitis and 
emphysema. Of these, 300 are known carcinogens that contribute 
to the development of cancer of the respiratory, digestive and urinary 
tracts, amongst others. 
Thus, tobacco smoking is associated l¥ith an increased lisk of 
the follol¥ing diseases: 
Cancers: lung (>90% are smokers); lip; mouth; oesophagus; 
stomach; pancreas; colon; kidney; bladder; breast; cervix; 
leukaemia/lymphoma. 
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Coronarylcerebro-vascular disease: coronary artery disease 
(CAD); stroke; peripheral vascular disease. 
Chronic lung disease: chronic obstructive pulmonary disease 
(COPD)/emphysema; recurrent chest infection; exacerbation 
of asthma. 
Complications of pregnancy: pre-eclamptic toxaemia; intra-
uterine growth retardation; pre-tenn delivery; low birth weight; 
perinatal death. 
Mouth disease, dyspepsia, gastric ulcers. 
• Non-in sulin dependent diabetes mellitu s (N IDDM) , 
osteoporosis, hypothyroidism, reduced ferti lity 
Passive smoking too is associated with a raised 11Sk of disease, 
as follows: 
lung cancer (increased by 30-35%) 
CAD (increases death by 25%) 
exacerbation of allergies, eczema & asthma 
decreased lung function 
bronchitis 
cot death 
otitis media in children 
On the other hand, quitting smoking does have its benefits. 
First of all, it reduces the risk of acquiring a disease. For example, 
if one stops smoking today, by tomorrow he/she will have halved the 
chance of dying of a heart attack (British Medical Association Annual 
Scientific Meeting, Malta, 22-26 September 1992) Cessation at 
the age of 50 halves the added hazards of smoking, while quitting 
at 30 avoids almost all of itlo. Secondly, it also benefi ts patients 
already having a disease, by arresting the progression of the disease 
(unless it is cancer). In fact, stopping at the ages of 60, 50, 40, or 
30 years results in gains of approximately 3,6,9, or 10 years in life 
expectancy respectivelyl° 
Smoking cessation 
Stopping smoking is a process: advice can start it off or help it along 
the stages of contemplation (based on the Prochaska & Diclemente 
'stages of change' model - see Figure 2). Simple advice from a 
general practitioner to stop, reinforced by a leaflet and warning of 
follow-up, resulted in 5% of patients not smoking one year laterl1 
Individual counselling can help smokers quit, being 1.5 times more 
effective than controP2 
Family doctors play an important role in tobacco control 
through delivering positive health messages counteracting tobacco 
use and promotion, and by assisting in smoking cessation through 
counselling and pharmacotherapy. Thus it is important to know 
which diseases are smoking related, inform patients on the dangers 
of smoking (with the benefits of quitting), and advise all those who 
smoke to quit and how. This may be done by using the follmving 
5 A's technique I) : 
• Ask about smoking at every opportunity; 
• Advise all smokers to quit; 
• Assess readiness to stop smoking; 
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Figure 2: 
Process of changes of attitude in stopping 
smoking (adapted from Raw2) 
"Contented" 
smokers ~ 
Thinking 
about stopping 
Relapsing 
• Ass ist the patient in stopping; 
• Arrange follow-up visits. 
1. ASK about smoking status 
~ 
lIE 
All patients should be asked if they smoke, with smoking status being 
recorded in their medical record. For example, if paper-based files 
are used, a black sticker could identify smokers, with a yellow sticker 
used for those trying to quit and a blue sticker for non- or ex-smokers. 
The status of ex-smokers should be reinforced by congratulating them 
on their achievement. Of course, it is important that such records 
are kept up to date. 
2. ADVISE benefit of stopping 
All smokers should be advised to quit, and the best way to do this is in 
a personalised and appropriate manner by linking such advice to the 
patient's situation , symptoms and clinical condition (see Table 1). 
Secondly, when counselling a smoker to quit, the dangers of 
smoking must be balanced vvith the benefits of stopping, trying to 
use terms which are easily understood, as shown in Table 2. 
3. ASSESS motivation to stop 
Smokers' readiness to quit should then be assessed by being asked a 
direct and simple question: "Do you want help to stop smoking?" 
Table 1: Linking Cessation Advise 
to Smokers' Circumstances 
Decide 
to try 
t 
Trying 
to stop 
t Stoppmg 
t 
Staying 
stopped 
Situations Symptoms Conditions 
• Parent of young • Cough, sputum • Vascular diseases 
children production • Hypertension 
• Women on the pill • Chest pain, shortness • ReClllTent RTI's 
• Pregnancy & of breath • Diabetes mellitus 
post delivery • Hyperlipidaemia 
• Before and after • Allergy 
surgery • COPD/asthma 
• Peptic ulcer 
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Table 2: 
Dangers of smoking versus benefits of quitting 
Smoking Is Dangerous It is worth stopping 
9 in 10 of deaths from lung cancer 
and COPD, and 1 in 4 of heart 
disease, are caused by smoking! 
If you stop smoking today, by 
tomorrow you will have halved your 
chances of dying of a heart attack 
From an average 1,000 young men 
who smoke cigarettes regularly 
QUitting at 30 avoids almost all the 
added hazards of smoking, while 
quitting at the age of 50 halves the 
increased risks 
• about 1 will be murdered 
• about 6 will be killed on the roads 
• about 250 will be killed by tobacc02 
Table 3: 
If the client is not interested and says no, his/her decision 
should be respected. In such cases, he/she should Just be offered an 
information leaflet (available from the Health Promotion Department 
- see 'Resources'), advised to consider the matter further, and given 
an open invitation for further discussion. When the opportunity 
presents itself, the patient should be asked again during subsequent 
visits, but in a discrete and non-intrusive manner. 
If, on the other hand, the client is interested in quitting and 
wants help in doing so, he/she is then provided ,vith assistance in 
stopping. 
4. ASSIST in stopping 
Stopping is easy if the would-be quitter possesses the necessary want-
power and will-power. The family doctor should assist by providing 
useful self-help literature (available from the Health Promotion 
Department - see 'Resources') and offering appropriate support and 
counselling (see Table 3) 
Pharmacotherapy has been found to improve the chances 
of quitting. As such, the family doctor should recommend the 
use of nicotine replacement therapy (NRT) or bupropion (if not 
contraindicated) and provide accurate information and advice about 
them. However it must be emphasised that NRT and bupropion are 
only aids, and that willpower is still needed to stop smoking. 
Support and counselling tips for quitting smoking 
Prepare Carefully 
• Highlight reasons for quitting 
• Keep a smoking diary 
• Discuss withdrawal symptoms 
• Agree on a quit date 
• Quit with a friend 
• Study self-help literature 
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Wake up a non-smoker 
• Avoid temptation 
• Coping strategies (4Ds) 
- delay for 3 minutes 
- drink water/juice 
- distract oneself 
- deep breathing 
• Change regular routine 
• Take one day at a time 
• Eat healthy food 
• Regular exercise, adequate rest 
• "Cash not ash" 
Nicotine replacement therapy 
NRT has been found to increase the quit rates by 1.5-2 times, 
irrespective of the use of additional counsellingl4. It is available as 
patches, chnving gum, inhaler, nasal spray, lozenges and sublingual 
tablets, all of which are equally effective. NRT helps the motivated 
smoker to quit by redUCing the symptoms of nicotine \vithdrawal, 
while avoiding the hazards to the other constituents of tobacco . One 
should start off with higher doses for patients highly dependent and 
continue treatment for 3 months, tailing off the dose gradually before 
stopping. Contraindications to the use of NRT include arrhythmia 
and immediately after myocardial infarction, stroke and transient 
ischaemic attacks I '. 
Bupropion 
Bupropion can double the chance of quittingl6 The mode of action is 
unclear but is thought to involve a specific effect on noradrenaline and 
dopamine neurotransmission underlying nicotine addiction. Smokers 
over 18 years of age (under which bupropion is not recommended) 
start taking the tablets 1-2 weeks before their intended quit day (150 
mg daily for 6 days, then 150 mg twice daily) for 7-9 weeks in all . A 
1 in 1000 risk of seizures has been documented. Contraindications 
to the use of bupropion are a history of seizures, eating disorders, 
bipolar disorder; pregnancy; and breast-feedingl) 
Newly-approved drug for smoking cessation 
A new drug - varenicline - was approved in May 2006 by the US 
Food and Drug Administration after six clinical trials (including five 
randomised controlled trials - RCTs) demonstrated its effectiveness 
in helping cigarette smokers to stop l'. Varenicline was found to be 
superior to placebo in the 5 RCTs and more successful than bupropion 
in two of them. It is a nicotinic acetylcholine receptor partial agonist 
and is reported to reduce the urge to smoke and ease withdrawal 
symptoms, and to diminish the sense of satisfaction if smoking is 
resumedl8 However, Klesges et al19 have pointed out that, in 3 RCTs, 
nausea was reported by nearly 30% of participants taking varenicline, 
Significantly more than those taking bupropion or placebo. Following 
approval of varenicline by the European Medicines Evaluation Agency 
(EMEA) in September 2006, UK interim gUidelines I>' issued in 
November 2006 stated that it "looks to be an effec tive and welcome 
addition to our range of medications to help smokers stop". 
Referral to smoking cessation clinic 
Group behaviour therapy programmes for smoking cessation are more 
than twice as effective for helping people to stop smoking as being 
given self-help materials without face-to-face instruction and group 
suppOrt!ll. The family doctor may refer would-be quitters to Smoking 
Cessation Clinics run locally by the Health Promotion Department 
(see 'Resources') . 
An evaluation of Smoking Cessation Clinics in Malta canied out 
by Sammut21 studied 101 clients attending quit sessions of all smoking 
cessation clinics held during one year starting in October 1999. Of 
these, there were 27 who stopped smoking by the last session (27% 
immediate success rate). Six months after the end of the clinics, 10 
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of the quitters were still not smoking Cl 0% long-term success rate) 
This rate is low compared to international standards (20-30% and 
15-30% at one year in the UK and USA respectively), one possible 
reason being the non-mandatory use of NRT by clinics at the time. 
5. ARRANGE follow·up visits 
Follow-up of would-be quitters is important to enable discussion of 
their progress and any problems. Fears of busy family doctors that 
this arrangement will be time-consuming are unfounded. In actual 
fact , three visits at weekly intervals, followed by 3 visits at fortnightly 
intervals (ie. 6 appointments in all, lasting about 5 minutes each), 
add up to a grand total of just 30 minutes over 2 months. During 
these meetings, the doctor should maintain a positive attitude and 
encourage when despondent. Thus one must differentiate between 
a slip (one or two Cigarettes) and a relapse (going back to smoking 
on a regular basis), and remember the maxim quoted by Steele r "If 
at first you don't succeed - quit, quit again!" 
Conclusion 
Preventive measures in tobacco control involves knO\ving which 
diseases are related to smoking, informing patients on the dangers of 
smoking and the benefits of quitting, and advising all patien ts who 
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